Trade Kyntra Bio Inc - KYNB CFD

Trading Conditions

• Type: CFD
• Spread: 0.26
• Long position overnight funding adjustment: -0.02171%
• Short position overnight funding adjustment: -0.00052%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 7.22
• Open: 7.34
• 1-Year Change: 1690.24%
• Day's Range: 6.81 - 7.34

What is Kyntra Bio Inc (KYNB)?

Kyntra Bio Inc is a biotechnology company engaged in the discovery and development of novel therapeutics. Its research efforts focus on identifying and advancing drug candidates targeting various diseases, potentially including oncology and other therapeutic areas. The company employs scientific approaches to develop molecules with the aim of addressing unmet medical needs. Kyntra Bio operates within the pharmaceutical and biotechnology industries, with a commitment to innovation in drug discovery and development. Its pipeline consists of early-stage programs reflecting ongoing research activities.

Kyntra Bio Inc Stock Price Today: Live Overview

The price today is shaped by intraday market behavior, as Kyntra Bio Inc trades at $7.26. Its price fluctuated between $6.81 and $7.34, posting a daily change of -3.6011%.

FAQ: Kyntra Bio Inc (KYNB)

What is the current price of KYNB stock?

The current trading price is $7.26.

Does KYNB pay dividends?

Kyntra Bio Inc does not pay dividends.

Does KYNB have a formal corporate presence or regional headquarters in the UAE?

Kyntra Bio Inc operates in the UAE only through partners and distributors without an official office or subsidiary.

What is KYNB best known for?

Kyntra Bio Inc is most famous for its development of antibody-based therapeutics.

What assets are typically shown together with KYNB?

Commonly shown alongside KYNB: ADMA Biologics, Inc., Kura Oncology Inc, Summit Hotel Properties Inc